Borges Luis
- SEC CIK
- 0001684015
No open-market purchases or sales filed in the past year.
Current role at each company
- MGX Metagenomi Therapeutics, Inc.Chief Scientific Officeras of Apr 3, 2024
- IPSC Century Therapeutics, Inc.Chief Scientific Officeras of Apr 5, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Borges Luis as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
IPSC Century Therapeutics, Inc.
Chief Scientific Officer1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 23, 2023 (view filing) | Mar 21-23 | 2 days | Borges LuisChief Scientific Officer | SSale | −144.9K | $3.72 | −$539.6K | −36.8%249.1K after | 3 lots |